Ogilvie Syndrome in a COVID-19 Patient with Pneumonia, Absolute Tachyarrhythmia and Heart Failure: a Case Report
Abstract
The COVID-19 pandemic has recently spread worldwide presenting primarily in form of pneumonia. Gastrointestinal manifestations such as nausea, vomiting, diarrhoea and abdominal pain are less common than respiratory symptoms. However, critically ill patients may develop digestive complications including acute pseudo-obstruction of colon - Ogilvie syndrome. Gastrointestinal symptoms can manifest before the onset of typical respiratory symptoms. Common mucosal immune response underly both-pulmonary and gastrointestinal manifestations (high expression of angiotensin-converting enzyme 2 receptors). This article described a 75-year old female patient who arise Ogilvie syndrome during viral bilateral pneumonia induced by COVID-19. Patient also had an absolute tachyarrhythmia and hearth failure. Diameter of caecum, ascending and transverse colon was 12 to 14 cm. The walls of this segment of large bowel were deserosed, with threatening perforation. Right colectomy was performed. Nine days after the surgery, despite all therapeutic measures taken, there was a fatal outcome due to pulmonary thromboembolisation.
References
Ibrahim YS, Karuppasamy G, Parambil JV, Alsoub H, Al-Shokri SD. Case report: paralytic ileus: a potential extrapulmonary manifestation of severe COVID-19. Am J Trop Med Hyg 2020 Oct;103(4):1600-3.
Tse F, Borgaonkar M, Leontiadis GI. COVID-19: Advice from the Canadian Association of Gastroenterology for Endoscopy Facilities, as of March 16, 2020. J Can Assoc Gastroenterol 2020 Jun;3(3):147-9.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020 Mar 17;323(11):1061-9.
Azwar MK, Kirana F, Kurniawan A, Handayani S, Setiati S. Gastrointestinal presentation in COVID-19 in Indonesia: A case report. Acta Med Indones 2020 Jan;52(1):63-7.
Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of Covid patients with digestive symptoms in Hubei, China: A descriptictive, cross-sectional multicentric study. Am J Gastroenterol 2020;115(5):766-73.
Nobel YR, Phipps M, Zucker J, Lebwohl B, Wang TC, Sobieszczyk ME, et al. Gastrointestinal symptoms and coronavirus disease 2019: A case control study from United States. Gastroenterology 2020;59(1):373-5.
Ramachadran P, Onukogu I, Ghantas S, Gajedran M, Perisetti A, Goyal H, et al. Gastrointestinal symptoms and outcomes in hospitalized Corona virus disease 2019 patients. Dig Dis 2020;38:373-9.
Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020 Jul;5(7):667-78.
Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 2020 May;5(5):434-5.
Kaafarani HMA, El Moheb M, Hwabejire JO, Naar L, Christensen MA, Breen K, et al. Gastrointestinal complications in critical ill patients with COVID-19. Ann Surg 2020 Aug;272(2):e61-e62.
Sattar Y, Connerney M, Rauf H, Saini M, Ullah W, Mamtani S, et al. Three cases of COVID-19 disease with colonic manifestations. Am J Gastroenterol 2020 Jun;115(6):948-50.
Han C, Duan C, Zhang S, Spiegel B, Shi H, Wang W, et al. Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes. Am J Gastroenterol 2020 Jun;115(6):916-23.
Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther 2020 May;51(9):843-51.
Saeed U, Sellevoll HB, Young VS, Sandbaek G, Glomsaker T, Mala T. Covid-19 may present with acute abdominal pain. Br J Surg 2020 Jun;107(7):e186-e187.
Bastug A, Bodur H, Erdogan S, Gokcinar D, Kazancioglu S, Kosovali BD, et al. Clinical and laboratory features of COVID-19: Predictors of severe prognosis. Int Immunopharmacol 2020 Nov;88:106950. doi: 10.1016/j.intimp.2020.106950.
Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ, et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol 2020 Jul;251(3):228-48.
Zhang H, Li HB, Lyu JR, Lei XM, Li W, Wu G, et al. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int J Infect Dis 2020 Jul;96:19-24.
Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 2020 May;158(6):1831-3.e3.
Chen Y, Chen L, Deng Q, Zhang G, Wu K, Ni L, et al. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol 2020 Jul;92(7):833-40.
Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv 2020; 01.30.927806doi:10.1101/2020.01.30.927806.
Igic R. Pharmacologists view of the new corona virus. Scr Med 2020;51(1):6-8.
Khan Z, Mukhtar K, Roman G, Aun R, Hassan, Ahmed M, et al. Ogilvie syndroma in a patient with Covid-19 infection. Am J Gastroenterol 2020;115:862-3.
Wells CI, O'Grady G, Bissett IP. Acute colonic pseudo-obstruction: A systematic review of aetiology and mechanisms. World J Gastroenterol 2017 Aug 14;23(30):5634-44.
Bhayana R, Som A, Li MD, Carey DE, Anderson MA, Blake MA, et al. Abdominal imaging findings in COVID-19: preliminary observations. Radiology 2020 Oct;297(1):E207-E215.
Ashcroft J, Hudson VE, Davies RJ. COVID-19 gastrointestinal symptoms mimicking surgical presentations. Ann Med Surg (Lond) 2020 Jun 24;56:108-9.
Martindale A, Patel JJ, Taylor B, Warren M, Mc Glove SA. American Society for parenteral and enteral nutrition(ASPEN). Nutrition therapy in the patients with COVID-19 disease requiring ICU care. [Cited 1-May-2021] Available at: https://www.nutritioncare.org/uploadedFiles/Documents/Guidelines_and_Clinical_Resources/Nutrition%20Therapy%20COVID-19_SCCM-ASPEN.pdf.
Aguila EJT, Cua IHY, Fontanilla JAC, Yabut VLM, Causing MFP. Gastrointestinal manifestations of COVID-19: Impact on nutrition practices. Nutr Clin Pract 2020 Oct;35(5):800-5.
Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost 2020 Jul;18(7):1559-61.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).